Loading...

APC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APC_091809
C57BL/6 bone marrow cells stained with 1A8 APC
  • 1A8_APC_091809
    C57BL/6 bone marrow cells stained with 1A8 APC
Compare all formats See APC spectral data
Cat # Size Price Save
127613 25 µg ¥15,670
127614 100 µg ¥55,900
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  2. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  3. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  4. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  5. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  6. Jiang H, et al. 2022. Oxid Med Cell Longev. 2022:5064494. PubMed
  7. Nakayama A, et al. 2023. J Exp Med. 220: . PubMed
  8. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  9. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  10. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  11. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  12. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  13. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  14. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  15. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  16. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
  17. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  18. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  19. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  20. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  21. Li J, et al. 2022. Elife. 11:. PubMed
  22. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  23. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  24. Zhou M, et al. 2023. Biomed Pharmacother. 161:114530. PubMed
  25. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  26. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  27. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  28. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  29. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  30. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  31. Wenzek C, et al. 2022. iScience. 25:105540. PubMed
  32. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  33. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  34. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
  35. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
  36. Sharma A, et al. 2014. J Infect Dis. . PubMed
  37. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  38. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  39. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  40. Poli V, et al. 2021. iScience. 24:103256. PubMed
  41. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  42. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
  43. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  44. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  45. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  46. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  47. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  48. Han J, et al. 2022. FEBS J. 289:417. PubMed
  49. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  50. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  51. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
  52. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  53. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  54. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  55. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
  56. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
  57. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  58. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  59. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  60. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  61. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  62. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  63. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  64. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
  65. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  66. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  67. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  68. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  69. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
  70. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
  71. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
  72. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  73. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  74. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  75. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  76. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  77. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  78. Goldman E, et al. 2021. Cells. 10:. PubMed
  79. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  80. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  81. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  82. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  83. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  84. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  85. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  86. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  87. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  88. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  89. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  90. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
  91. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  92. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  93. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  94. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  95. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  96. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  97. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
  98. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  99. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  100. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  101. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  102. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  103. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  104. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  105. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  106. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
  107. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  108. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  109. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  110. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
  111. Cho K, et al. 2021. iScience. 24:103117. PubMed
  112. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  113. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  114. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  115. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
  116. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  117. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  118. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  119. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  120. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  121. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  122. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
  123. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  124. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  125. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  126. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  127. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
  128. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
  129. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  130. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  131. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  132. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  133. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  134. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  135. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
  136. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  137. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  138. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  139. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
  140. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
  141. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  142. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  143. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  144. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  145. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  146. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  147. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  148. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  149. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
  150. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  151. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
  152. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
  153. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
  154. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  155. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  156. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
  157. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
  158. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  159. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  160. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
  161. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  162. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  163. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  164. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  165. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  166. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  167. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
  168. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
  169. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  170. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  171. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  172. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  173. Molgora M, et al. 2020. Cell. 182:886. PubMed
  174. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  175. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  176. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  177. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  178. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  179. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  180. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  181. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  182. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  183. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  184. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  185. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  186. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  187. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  188. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  189. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
  190. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  191. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
  192. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  193. Wang S, et al. 2022. Blood. 140:171. PubMed
  194. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  195. Young K, et al. 2021. Cell Stem Cell. . PubMed
  196. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
  197. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
  198. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  199. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  200. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
RRID
AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
Ly-6G
Specificity Alt (DOES NOT SHOW ON TDS):
Ly-6G
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about Ly-6G on UniProt.org

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account